CPRX icon

Catalyst Pharmaceutical
CPRX

Overview Fund Activity

54 hedge funds and large institutions have $25M invested in Catalyst Pharmaceutical in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 5 closing their positions.

Holders
54
Holders Change
+5
Holders Change %
+10.2%
% of All Funds
1.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
8
Reduced
13
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ACA
1
Avoro Capital Advisors
New York
$1.2M
2
KCM
2
Kingdon Capital Management
New York
$794K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$3.14M
4
ARTA
4
A.R.T. Advisors
New York
$66K
5
VKH
5
Virtu KCG Holdings
New York
$57K

Top Sellers

1
GCP
1
GSA Capital Partners
United Kingdom
$0
2
BA
2
BlackRock Advisors
Delaware
$13K
3
Millennium Management
3
Millennium Management
New York
$336K
4
Goldman Sachs
4
Goldman Sachs
New York
$45K
5
CS
5
Credit Suisse
Switzerland
$17K
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of America
51
Bank of America
North Carolina
$2K +$431 +401 +27%
IA
52
IFP Advisors
Florida
$1K – – –
Carson Wealth (CWM LLC)
53
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
Bank of Montreal
54
Bank of Montreal
Ontario, Canada
$1K – – –
GCP
55
GSA Capital Partners
United Kingdom
– -$812K -745,077 Closed
TDC
56
Thompson Davis & Co
Virginia
– -$27K -24,920 Closed
NEPWA
57
New England Private Wealth Advisors
Massachusetts
– -$17K -15,554 Closed
Deutsche Bank
58
Deutsche Bank
Germany
– -$16K -15,000 Closed
Renaissance Technologies
59
Renaissance Technologies
New York
– -$16K -15,000 Closed
1 2
3